Instead of the two to three weeks taken by current treatments from American and European drug makers, the Shanghai-based company — set up by a group of veteran Chinese cell-therapy researchers — is churning out cancer-killing immune cells overnight.
Gracell plans to price its CAR-T treatment for about 500,000 yuan ($71,000), well below the $475,000 price tag for Novartis’ Kymriah, the Swiss company’s CAR-T therapy used to treat the type of blood cancer that Zhang had
lol churning out, what a choice of words. Yeah man, these unscrupulous Chinese are just churning out cheap vials of anticancer, who knows what the build quality on those things is amirite?
What do you mean are? I wake up, walk down to the factory, grab my shovel and start scooping piles of cancer-killing immune cells onto patients as they get passed down the conveyer belt. Because that's what real doctors do.
But at what cost?
$400,000
lol churning out, what a choice of words. Yeah man, these unscrupulous Chinese are just churning out cheap vials of anticancer, who knows what the build quality on those things is amirite?
What do you mean are? I wake up, walk down to the factory, grab my shovel and start scooping piles of cancer-killing immune cells onto patients as they get passed down the conveyer belt. Because that's what real doctors do.
The old Monty Burns Special